What is the significance of the erythrocyte EPA+DHA percentage (Omega-3 Index) for brain health and how does it relate to the design and interpretation of EPA and DHA intervention trials?
Omega-3 Index Test, a review (Nutrients 2021, PMID 33806218) — maintaining an optimal Omega-3 Index (8-11%) is linked to better brain health and should be used to guide EPA and DHA supplementation. The abstract for Omega-3 Index Test states no limitations.
Source: Nutrients 2021, PMID 33806218 ↗ · Research map · How Magellan grades evidence · evidence confidence: medium
Nutrients · 2021 · PMID 33806218 · DOI 10.3390/nu13041074
Maintaining an optimal Omega-3 Index (8-11%) is linked to better brain health and should be used to guide EPA and DHA supplementation.
The question
What is the significance of the erythrocyte EPA+DHA percentage (Omega-3 Index) for brain health and how does it relate to the design and interpretation of EPA and DHA intervention trials?
What they tested
The abstract implies that an optimal Omega-3 Index is crucial for brain health and that using the Omega-3 Index to guide EPA and DHA interventions could improve trial outcomes and clarify their effects.
How they did it
This is a review article summarizing existing evidence regarding the Omega-3 Index, its association with brain health outcomes from epidemiological studies, and its implications for the design and interpretation of EPA and DHA intervention trials.
What they found
The Omega-3 Index ranges from 2% to 20%, with an optimal range of 8-11%. A lower Omega-3 Index is associated with increased risks for total mortality, ischemic stroke, reduced brain volume, impaired cognition, accelerated dementia progression, psychiatric diseases, and compromised complex brain functions. Intervention trials often yield neutral results when not considering baseline blood levels, but when trial results are evaluated using measured blood levels of EPA and DHA, effects are larger and align with epidemiological findings.
| Lower Bound | 8 | |
|---|---|---|
| Upper Bound | 11 |
The optimal Omega-3 Index, expressed as a percentage of EPA+DHA in erythrocytes, is between 8% and 11%.
What it means
The Omega-3 Index is a valuable biomarker for assessing EPA and DHA status, reflecting brain health risks, and should be used to guide the design and interpretation of future EPA and DHA intervention trials for more targeted and effective use.
Limitations
The abstract does not explicitly state limitations of the Omega-3 Index itself or the reviewed studies, but it highlights that many intervention trials have produced neutral results due to design flaws (e.g., not considering baseline blood levels).
Where the published abstract does not list limitations, we say so rather than inventing them. Read the full paper on PubMed before drawing conclusions.
The paper at a glance
| Magellan’s evidence label | Erythrocyte EPA+DHA percentage (our label for this citation — see PubMed for the paper’s own title and authors) |
|---|---|
| Journal | Nutrients |
| Year | 2021 |
| PMID | 33806218 ↗ |
| DOI | 10.3390/nu13041074 ↗ |
| Topic | Brain, cognition & mood |
Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗
Where Magellan uses this paper
This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.
Omega-3 Index Test
In prospective cohort studies and pooled analyses spanning dozens of cohorts, higher blood levels of EPA + DHA have been consistently associated with lower all-cause and cardiovascular mortality - across ten cohorts an Omega-3 Index near 8% carried roughly 30% lower fatal coronary heart disease risk than one near 4%…
The Omega-3 Index is a blood biomarker defined as the amount of the long-chain marine omega-3 fatty…
Research describes the compound or intervention studied. It is not a claim about any specific product.
Molecules & mechanisms in this paper
Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.
Cite this page
These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.
Magellan Longevity. (2026). What is the significance of the erythrocyte EPA+DHA percentage (Omega-3 Index) for brain health and how does it relate to the design and interpretation of EPA and DHA intervention trials? [Plain-English summary of Nutrients 2021, PMID 33806218, DOI 10.3390/nu13041074]. Magellan Longevity. https://magellanlongevity.com/study/s143.html@misc{magellan_s143,
title = {What is the significance of the erythrocyte EPA+DHA percentage (Omega-3 Index) for brain health and how does it relate to the design and interpretation of EPA and DHA intervention trials?},
author = {{Magellan Longevity}},
year = {2026},
howpublished = {\url{https://magellanlongevity.com/study/s143.html}},
note = {Plain-English summary of PubMed PMID 33806218; DOI 10.3390/nu13041074; Nutrients 2021. Reviewed by Gabriel Radu, DO},
urldate = {2026-08-11}
}https://magellanlongevity.com/study/s143.htmlRelated studies in the Magellan library
- Omega-3 fatty acids and mortality in patients referred for coronary angiographyAtherosclerosis · 2016 · PMID 27397734
- Effect of omega-3 fatty acids on cardiovascular outcomesEClinicalMedicine · 2021 · PMID 34505026
- Effect of Omega-3 Dosage on Cardiovascular Outcomes: An Updated Meta-Analysis of…Mayo Clin Proc · 2020 · PMID 32951855
- Potential Modulation of Inflammation by Probiotic and Omega-3 Supplementation in Elderly with…Nutrients · 2022 · PMID 36235651
- What are the effects of increased intake of fish- and plant-based omega-3 fats (LCn3 and ALA)…Cochrane Database Syst Rev · 2020 · PMID 32114706
- Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with DementiaAging Dis · 2021 · PMID 34221541
Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →